Role of secreted oxidative stress-induced factors (SOXFs) in the pathogenesis of atherosclerosis

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 12, 2004, Pages 1256-1259

  Jin, Z G ^b   Berk, B C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL GROWTH; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; INFLAMMATION; OXIDATIVE STRESS; RESTENOSIS; VASCULAR LESION; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; CYCLOPHILIN A; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 11144319343     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25: 155-61.
2. Abe J, Berk BC. Reactive Oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 1998; 8: 59-64.
3. Omar HA, Cherry PD, Mortelliti MP, Burke-Wolin T, Wolin MS. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. Circ Res 1991; 69: 601-8.
4. Baas AS, Berk BC. Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. Circ Res 1995; 77: 29-36.
5. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 1994; 266: H2568-H2572.
6. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-23.
7. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997; 81: 1-7.
8. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995; 270: 296-9.
9. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activation in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-8.
10. Halliwell B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 1989; 70: 737-57.
11. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70: 593-9.
12. Rao GN, Lassegue B, Griendling KK, Alexander RW, Berk BC. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: Role of protein kinase C. Nucl Acids Res 1993; 21: 1259-63.
13. Nunes GL, Sgoutas DS, Redden RA et al. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 1995; 15: 156-65.
14. Nunes GL, Robinson K, Kalynych A, King III SB, Sgoutas DS, Berk BC. Vitamins C and E inhibit O2- production in the pig coronary artery. Circulation 1997; 96: 3593-601.
15. Abe J, Kusuhara M, Ulevitch RJ, Lee JD, Berk BC. The role of big MAP kinase 1 (BMK1) as a redax sensitive kinase in vascular smooth muscle cells. Circulation 1996; 94: 1-280 (abstract).
16. Abe J, Berk BC. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J Biol Chem 1999; 274: 21003-10.
17. Abe J, Okuda M, Huang Q, Yoshizumi M, Berk BC. Reactive oxygen species activate p90 ribosomal S6 kinase via fyn and ras. J Biol Chem 2000; 275: 1739-48.
18. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC. Src and cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 2000; 275: 11706-12.
19. Liao D-F, Jin Z-G, Baas AS et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 2000; 275: 189-96.
20. Jin ZG, Melaragno MG, Liao DF et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000; 87: 789-96.
21. Liao DF, Baas AS, Daum G, Berk BC. Purification of a secreted protein factor induced by reactive oxygen species (ROS) in vascular smooth muscle cells (VSMC). Circulation 1997; 96: 1-901.
22. Meloche S, Seuwen K, Pages G, Pouysségur J. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol Endocrinol 1992; 6: 845-54.
23. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001; 81: 999-1030.
24. Yates III JR, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995; 67: 1426-36.
25. Figeys D, Ducret A, Yates JR, Aebersold R. Protein identificaticn by solid phase microextraction-capillary zone electrophoresis-microspray-tandem mass spectrometry. Nature Biotechnol 1996; 14: 1579-83.
26. Suh YA, Arnold RS, Lassegue B et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82.
27. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 1996; 79: 748-56.
28. Zhao Z, Francis CE, Welch G, Loscalzo J, Ravid K. Reduced glutathione prevents nitric oxide-induced apoptosis in vascular smooth muscle cells. Biochim Biophys Acta 1997; 1359: 143-52.
29. Sherry B, Yarlett N, Strupp A, Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA 1992; 89: 3511-5.
30. Xu Q, Leiva MC, Fischkoff SA, Handschumacher RE, Lyttle CR. Leukocyte chemotactic activity of cyclophilin. J Biol Chem 1992; 267: 11968-71.
31. Kim SH, Lessner SM, Sakurai Y, Galis ZS. Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 2004; 164: 1567-74.
32. Allain F, Vanpouille C, Carpentier M, Slomianny MC, Durieux S, Spik G. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc Natl Acad Sci USA 2002; 99: 2714-9.
33. Jin ZG, Lungu AO, Xie L, Wang M, Wong C, Berk BC. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol 2004; 24: 1186-91.
34. Gong KW, Zhu GY, Wang LH, Tang CS. Effect of active oxygen species on intimal proliferation in rat aorta after arterial injury. J Vasc Res 1996; 33: 42-6.
35. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49: 208-15.